Legacy Wealth Asset Management LLC Sells 216 Shares of Encompass Health Co. (NYSE:EHC)

Legacy Wealth Asset Management LLC trimmed its stake in Encompass Health Co. (NYSE:EHC) by 3.2% during the fourth quarter, Holdings Channel reports. The fund owned 6,468 shares of the company’s stock after selling 216 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Encompass Health were worth $597,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of EHC. UMB Bank n.a. lifted its stake in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the 3rd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. grew its stake in shares of Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Encompass Health in the 2nd quarter worth about $58,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Up 0.3 %

Shares of NYSE EHC opened at $94.68 on Friday. The business has a 50-day moving average of $97.39 and a 200-day moving average of $93.94. The firm has a market capitalization of $9.54 billion, a price-to-earnings ratio of 22.87, a PEG ratio of 1.09 and a beta of 0.89. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12 month low of $69.76 and a 12 month high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the firm earned $0.86 EPS. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. Sell-side analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Barclays increased their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Finally, Royal Bank of Canada raised their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.